Bulletin
Investor Alert

New York Markets Close in:

Genmab A/S ADR

NAS: GMAB

GO
/marketstate/country/us

Market open

/zigman2/quotes/203049016/composite

$

30.38

Change

+0.79 +2.67%

Volume

Volume 334,866

May 19, 2022, 1:43 p.m.

Real time quotes

/zigman2/quotes/203049016/composite

Previous close

$ 29.59

$ 30.38

Change

+0.79 +2.67%

Day low

Day high

$29.96

$30.60

Open
Open: 29.99

52 week low

52 week high

$27.42

$49.07

Open

Market cap

$19.65B

Average volume

683,234

P/E ratio

41.89

Rev. per Employee

$1.11M

EPS

0.72

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/gmab

MarketWatch News on GMAB

  1. Genmab downgraded to underweight from equal weight at Morgan Stanley

    10:46 a.m. Sept. 7, 2021

    - Tomi Kilgore

  2. Covid Vaccine Could Be a Drug Industry Game Changer

    10:30 a.m. Nov. 16, 2020

    - Barron's Online

  3. AbbVie Can Withstand Humira’s Decline With New Drugs

    10:30 a.m. June 10, 2020

    - Barron's Online

  4. AbbVie to pay Genmab $750 mln upfront, up to $3.15 bln in milestone payments as part of cancer collaboration

    6:02 a.m. June 10, 2020

    - Tomi Kilgore

  5. Biotech ETFs Are Soaring. These Four Are Still Worth Considering.

    11:46 a.m. June 2, 2020

    - Barron's Online

  6. Amgen sees positive results in blood cancer trial

    9:21 a.m. Dec. 10, 2019

    - MarketWatch.com

/news/nonmarketwatch/company/us/gmab

Other News on GMAB

  1. Genmab A/S 2022 Q1 - Results - Earnings Call Presentation

    12:36 a.m. May 12, 2022

    - Seeking Alpha

  2. Genmab A/S (GMAB) Q1 2022 Earnings Call Transcript

    9:30 p.m. May 11, 2022

    - Motley Fool

  3. Genmab A/S Q1 2022 Earnings Preview

    12:24 p.m. May 10, 2022

    - Seeking Alpha

  4. Should You Buy Genmab (GMAB) Ahead of Earnings?

    10:35 a.m. May 10, 2022

    - Zacks.com

  5. IDNA: A Long Term Prospect, Slowly Overcoming The Bearish Rally

    2:21 p.m. April 29, 2022

    - Seeking Alpha

  6. 3 Things About BioNTech That Smart Investors Know

    6:18 a.m. April 29, 2022

    - Motley Fool

  7. Genmab (GMAB), AbbVie's Epcoritamab Successful in LBCL Study

    10:01 a.m. April 14, 2022

    - Zacks.com

  8. Seagen (SGEN) Inks ADC Deal With Sanofi for Cancer Targets

    10:07 a.m. March 18, 2022

    - Zacks.com

  9. Genmab: A Biotech Company On The Rise

    5:00 p.m. March 12, 2022

    - Seeking Alpha

  10. Genmab A/S 2021 Q4 - Results - Earnings Call Presentation

    2:45 a.m. Feb. 17, 2022

    - Seeking Alpha

  11. Genmab A/S (GMAB) Q4 2021 Earnings Call Transcript

    10:30 p.m. Feb. 16, 2022

    - Motley Fool

  12. IDNA: Healthcare Dashboard For February

    10:00 a.m. Feb. 16, 2022

    - Seeking Alpha

  13. Notable earnings before Wednesday's open

    11:22 a.m. Feb. 15, 2022

    - Seeking Alpha

  14. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/gmab

Press Releases on GMAB

  1. Genmab and Synaffix Enter into License Agreement for ADC Technology

    10:00 a.m. Jan. 4, 2022

    - PR Newswire - PRF

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.